Cargando…
CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells
BACKGROUND: There is very limited evidence on biomarkers for evaluating the clinical behavior and therapeutic response in rectal cancer (RC) with positive expression of cancer stem cells (CSCs). METHODS: An exploratory prospective study was conducted, which included fresh samples of tumor tissue fro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514348/ https://www.ncbi.nlm.nih.gov/pubmed/37746252 http://dx.doi.org/10.3389/fonc.2023.1258863 |